Search
for

    Sort by

    Research 871–900 of 1000+

    1. 8273 ACTH-Dependent Cushing's Syndrome Due To Metastatic Cervical Cancer: A Case Report Journal of the Endocrine Society · 2024
    2. Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs DSpace@MIT (Massachusetts Institute of Technology) · 2018
    3. Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs Neoplasia · 2018 · 32 citations
    4. METTL1-mediated m7G tRNA modification drives papillary thyroid cancer progression and metastasis by regulating the codon-specific translation of TNF-α Cell Death and Disease · 2025 · 3 citations
    5. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma British Journal of Dermatology · 2012 · 173 citations
    6. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. PubMed · 2003 · 79 citations
    7. The Effect of Mushroom Beta‐Glucans from Solid Culture of <i>Ganoderma lucidum</i> on Inhibition of the Primary Tumor Metastasis Evidence-based Complementary and Alternative Medicine · 2014 · 23 citations
    8. Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer Cancer Chemotherapy and Pharmacology · 2012 · 9 citations
    9. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    10. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Asia-Pacific Journal of Clinical Oncology · 2018 · 4 citations
    11. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer ESMO Gastrointestinal Oncology · 2024
    12. Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study Frontiers in Cell and Developmental Biology · 2024
    13. The efficacy of scalp-cooling system for the prevention of chemotherapy-induced hair loss in metastatic breast cancer patients treated with eribulin Annals of oncology · 2018
    14. Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Journal of Clinical Oncology · 2018
    15. MiR-325-3p functions as a suppressor miRNA and inhibits the proliferation and metastasis of glioma through targeting FOXM1 Journal of Integrative Neuroscience · 2021 · 16 citations
    16. Inferring Spatially Resolved Transcriptomics Data from Whole Slide Images for the Assessment of Colorectal Tumor Metastasis: A Feasibility Study bioRxiv (Cold Spring Harbor Laboratory) · 2022
    17. Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer 2026
    18. A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer Cancer Research Communications · 2026
    19. Ectopic Expression of a Truncated Isoform of Hair Keratin 81 in Breast Cancer Alters Biophysical Characteristics to Promote Metastatic Propensity Advanced Science · 2023
    20. Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study Cancer Communications · 2021 · 147 citations
    21. Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition Cell stem cell · 2016 · 174 citations
    22. Cutaneous adverse effects of targeted therapies Journal of the American Academy of Dermatology · 2015 · 149 citations
    23. Resolution of paraneoplastic alopecia following surgical removal of a pancreatic carcinoma in a cat Journal of Small Animal Practice · 1999 · 52 citations
    24. Paraneoplastic alopecia associated with internal malignancies in the cat Veterinary Dermatology · 1997 · 48 citations
    25. The Comparison of In Vitro Photosensitizing Efficacy of Curcumin-Loaded Liposomes Following Photodynamic Therapy on Melanoma MUG-Mel2, Squamous Cell Carcinoma SCC-25, and Normal Keratinocyte HaCaT Cells Pharmaceuticals · 2021 · 48 citations
    26. Review of Scalp Alopecia due to a Clinically Unapparent or Minimally Apparent Neoplasm (SACUMAN) Acta dermato-venereologica · 2006 · 32 citations
    27. Alopecia neoplastica simulating alopecia areata and antedating the detection of primary breast carcinoma Journal of Cutaneous Pathology · 1994 · 30 citations
    28. Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy Archives of Dermatology · 1994 · 25 citations
    29. RASopathic alopecia: Hair changes associated with vemurafenib therapy Journal of The American Academy of Dermatology · 2015 · 21 citations
    30. Vitamina D y la piel. Una revisión para dermatólogos Actas Dermo-Sifiliográficas · 2019 · 16 citations